Content Search Navigation Sitemap Contact Find contact details below tailored to the nature of your enquiry. Life Science Investment Opportunities 2nd Floor, 8 Bloomsbury Street, London, WC1B 3SR contact@synconaltd.com +44 (0)20 3981 7909 Shareholder enquiries MUFG Corporate Markets (Guernsey) Limited +44 (0)371 664 0300 (UK) +44 (0)371 664 0300 (ROW) Media enquiries FTI Consulting Ben Atwell / Natalie Garland-Collins / Tim Stamper +44 (0)20 3727 1000 syncona@fticonsulting.com Careers at Syncona careers@synconaltd.com Investor enquiries +44 (0)20 3981 7909 investorrelations@synconaltd.com Related content About View this section View this section Who we are NAV Growth Framework View this section View this section Who we are NAV Growth Framework Our people View this section View this section Board of Directors View this section View this section Board of Directors Portfolio View this section View this section Commercial companies Overview Autolus Therapeutics Late-stage clinical companies Overview Beacon Therapeutics Spur Therapeutics Clinical companies Overview iOnctura Quell Therapeutics Anaveon Mosaic Therapeutics Resolution Therapeutics Pre-clinical companies Overview Purespring Therapeutics Forcefield Therapeutics OMass Therapeutics Kesmalea Therapeutics Yellowstone Biosciences Slingshot Therapeutics Previous portfolio companies Overview Gyroscope Therapeutics Blue Earth Nightstar Neogene Therapeutics 14MG Azeria Therapeutics Clade Therapeutics View this section View this section Commercial companies Overview Autolus Therapeutics Overview Autolus Therapeutics Late-stage clinical companies Overview Beacon Therapeutics Spur Therapeutics Overview Beacon Therapeutics Spur Therapeutics Clinical companies Overview iOnctura Quell Therapeutics Anaveon Mosaic Therapeutics Resolution Therapeutics Overview iOnctura Quell Therapeutics Anaveon Mosaic Therapeutics Resolution Therapeutics Pre-clinical companies Overview Purespring Therapeutics Forcefield Therapeutics OMass Therapeutics Kesmalea Therapeutics Yellowstone Biosciences Slingshot Therapeutics Overview Purespring Therapeutics Forcefield Therapeutics OMass Therapeutics Kesmalea Therapeutics Yellowstone Biosciences Slingshot Therapeutics Previous portfolio companies Overview Gyroscope Therapeutics Blue Earth Nightstar Neogene Therapeutics 14MG Azeria Therapeutics Clade Therapeutics Overview Gyroscope Therapeutics Blue Earth Nightstar Neogene Therapeutics 14MG Azeria Therapeutics Clade Therapeutics Sustainability View this section View this section Our approach to sustainability reporting Syncona Fellowship Sustainability policies View this section View this section Our approach to sustainability reporting Syncona Fellowship Sustainability policies The Foundation News & insights View this section View this section News Insights & articles Publications & presentations View this section View this section News Insights & articles Publications & presentations Investors View this section View this section Results and presentations RNS and inside information Share price centre Governance Our Committees Financial calendar Events calendar Analysts and advisers Shareholder information Overview Regulatory publications Shareholder documents FAQs View this section View this section Results and presentations RNS and inside information Share price centre Governance Our Committees Financial calendar Events calendar Analysts and advisers Shareholder information Overview Regulatory publications Shareholder documents Overview Regulatory publications Shareholder documents FAQs Contact Search